cancer

Roche dives further into cancer cell therapy with Adaptimmune deal
Pharmaforum
Tue, 09/7/21 - 10:57 am
Roche
cell therapy
cancer
Adaptimmune Therapeutics
Startup Modulus embraces AI to design better NK cell therapies for cancer
MedCity News
Mon, 09/6/21 - 08:55 pm
Modulus Thearpeutics
natural killer cell therapies
cancer
artificial intelligence
FibroGen, fresh off data manipulation scandal, touts win in cancer patients without revealing data
Endpoints
Wed, 08/25/21 - 11:20 am
FibroGen
roxadustat
cancer
anemia
clinical trials
data manipulation
Study: Youth cancer trials should collect more patient-reported data for interventions
Fierce Biotech
Thu, 08/19/21 - 11:12 am
clinical trials
patient-reported outcomes
cancer
pediatric
oncology
GSK's Jemperli follows Merck's Keytruda with FDA nod to target certain tumors regardless of location
Fierce Pharma
Wed, 08/18/21 - 11:08 am
GSK
Jemperli
FDA
cancer
Merck
Keytruda
Analysis: Real-world studies of cancer drugs suffer from poor quality
RAPS.org
Thu, 08/12/21 - 12:13 am
oncology
cancer
RWE
real world evidence
real world data
FDA shoots down Spectrum's neutropenia drug, citing manufacturing issues
Endpoints
Fri, 08/6/21 - 11:06 am
Spectrum Pharmaceuticals
FDA
neutropenia
cancer
Rolontis
Gilead's Kite, Appia Bio to Collaborate on Allogeneic Cell Therapies for Cancer
Marketwatch
Thu, 08/5/21 - 11:04 am
Gilead Sciences
Kite Pharma
Appia Bio
cancer
cell therapy
Can mRNA vaccines do for cancer what they did with Covid-19?
MedCity News
Wed, 08/4/21 - 10:56 pm
vaccines
MRNA
cancer
COVID-19
Moderna Bolsters mRNA Oncology Business with Autolus' Proprietary Binders
BioSpace
Tue, 08/3/21 - 10:54 am
Autolus Therapeutics
Moderna Therapeutics
RNA
cancer
Eli Lilly hands Kumquat Biosciences $70M to kick off cancer drug R&D alliance
MedCity News
Thu, 07/29/21 - 11:03 am
Eli Lilly
Kumquat Biosciences
R&D
immuno-oncology
cancer
Amgen pays $900M for Teneobio and bets bigger on next-gen antibody drugs
BioPharma Dive
Wed, 07/28/21 - 07:22 pm
Amgen
M&A
Teneobio
cancer
antibodies
Artios Adds $153M to the Bank Amidst a Year of Major Collab Deals
BioSpace
Tue, 07/27/21 - 04:29 pm
Artios Pharma
DNA Damage Response
funding
cancer
DDR pathway
Bristol Myers Squibb catches the SHP2 wave in a new collaboration deal with BridgeBio
Endpoints
Tue, 07/27/21 - 10:40 am
Bristol Myers Squibb
SHP2 inhibitors
Opdivo
BridgeBio
cancer
Frontier Medicines raises $88M for R&D, including potential rival to Amgen cancer drug
MedCity News
Wed, 07/21/21 - 12:06 am
Frontier Medicines
Amgen
cancer
Lumakras
BioNTech returns to cancer roots with deal for Gilead cell therapy factory
BioPharma Dive
Mon, 07/19/21 - 11:10 pm
BioNTech
cancer
Gilead Sciences
Kite Pharma
cell therapy
Rome, backed by Arch and GV, hires science leaders to hit targets in “junk DNA”
Fierce Biotech
Mon, 07/19/21 - 11:02 am
Rome Therapeutics
junk DNA
cancer
autoimmune
Seagen veteran-led ProfoundBio gets $55M to bring cancer drugs to the clinic
MedCity News
Mon, 07/12/21 - 11:32 pm
ProfoundBio
cancer
antibody-drug conjugate
funding
Seagen
Biotech startup using AI to take guesswork out of cancer drug selection raises $70M
MedCity News
Thu, 07/8/21 - 11:45 pm
Xilis
artificial intelligence
funding
cancer
oncology
Study: Prices for new cancer drugs double over past decade
UPI
Mon, 07/5/21 - 09:56 pm
cancer
drug pricing

Pages